Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

New cytokine-targeted therapies show promise for treating alopecia areata.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Blocking certain proteins on immune cells may help treat alopecia areata.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Immunoadsorption successfully treated a man's resistant polymyositis.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.